The most interesting thing here is the open-source bio startup aspect. This is a bold step, and I hope it prompts more startups to go this direction.
They are clearly at the early stage of tech dev. And the reward of $200k for the polymerase to allow longer reads seems pretty low to me... unless you're a grad student and the university doenst take your IP...
Honestly it's pretty hard to get lab access without somebody also getting rights to your IP, and labs are a bit more expensive than setting up an H100, so it might be tough going.
Even if no external party solves their polymerase problem I have a good feeling about this direction though. Godspeed.
They are clearly at the early stage of tech dev. And the reward of $200k for the polymerase to allow longer reads seems pretty low to me... unless you're a grad student and the university doenst take your IP...
Honestly it's pretty hard to get lab access without somebody also getting rights to your IP, and labs are a bit more expensive than setting up an H100, so it might be tough going.
Even if no external party solves their polymerase problem I have a good feeling about this direction though. Godspeed.